# EDGAR Filing Document

**Accession Number:** 0001608126
**File Stem:** 0001567619-23-002450
**Filing Date:** 2023-2
**Character Count:** 8466
**Document Hash:** 76643080747ac8cdfd7e244761ebb8fa
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001567619-23-002450.hdr.sgml**: 20230213

**ACCESSION NUMBER**: 0001567619-23-002450

**CONFORMED SUBMISSION TYPE**: 13F-HR

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230213

**DATE AS OF CHANGE**: 20230213

**EFFECTIVENESS DATE**: 20230213

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Finepoint Capital LP
- **CENTRAL INDEX KEY:** 0001608126
- **IRS NUMBER:** 462183973
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 13F-HR
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-16580
- **FILM NUMBER:** 23615778

**BUSINESS ADDRESS:**
- **STREET 1:** 500 BOYLSTON STREET
- **STREET 2:** 24TH FLOOR
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02116
- **BUSINESS PHONE:** (617) 336-2200

**MAIL ADDRESS:**
- **STREET 1:** 500 BOYLSTON STREET
- **STREET 2:** 24TH FLOOR
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02116

### FORM 13F COVER PAGE

**Report for the Calendar Year or Quarter Ended:** 12-31-2022

**Check here if Amendment** [ ] **Amendment Number:** 

**This Amendment (Check only one.):** [ ] is a restatement.

[ ] adds new holdings entries.

**Institutional Investment Manager Filing this Report:**

**Name:** Finepoint Capital LP<br>**Address:** 500 BOYLSTON STREET<br>24TH FLOOR<br>BOSTON, MA 02116

**Form 13F File Number:** 028-16580

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

**Person Signing this Report on Behalf of Reporting Manager:**

**Name:** Stacy L. Vezina<br>**Title:** General Counsel<br>**Phone:** 617-336-2212

**Signature, Place, and Date of Signing:**

/s/ Stacy L. Vezina  Boston, MA  02-13-2023<br>[Signature]  [City, State]  [Date]

**Report Type (Check only one.):**

[x] **13F HOLDINGS REPORT.** (Check here if all holdings of this reporting manager are reported in this report.)

[ ] **13F NOTICE.** (Check here if no holdings are reported in this report, and all holdings are reported by other reporting manager(s).)

[ ] **13F COMBINATION REPORT.** (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)

### Form 13F Summary Page

**Report Summary:**

**Number of Other Included Managers:** 0

**Form 13F Information Table Entry Total:** 44

**Form 13F Information Table Value Total:** $309294

      (round to nearest dollar)

**List of Other Included Managers:**

Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.

[If there are no entries in this list, state “NONE” and omit the column headings and list entries.]

**NONE**

### FORM 13F INFORMATION TABLE

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | VALUE (x$1000) | SHRS OR PRN AMT | SH/PRN | PUT/CALL | INVESTMENT DISCRETION | OTHER MANAGER | VOTING AUTHORITY | VOTING AUTHORITY | VOTING AUTHORITY |
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | VALUE (x$1000) | SHRS OR PRN AMT | SH/PRN | PUT/CALL | INVESTMENT DISCRETION | OTHER MANAGER | SOLE | SHARED | NONE |
| ACADIA PHARMACEUTICALS INC | COM | 004225108 |  | 18735 | 1176830 | SH |  | SOLE |  | 1176830 | 0 | 0 |
| AFTERNEXT HEALTHTECH ACQUISITION CORP | *W EXP 99/99/999 | G01109126 |  | 28 | 366666 | SH |  | SOLE |  | 366666 | 0 | 0 |
| ALGOMA STL GROUP INC | COM | 015658107 |  | 20411 | 3219441 | SH |  | SOLE |  | 3219441 | 0 | 0 |
| AMICUS THERAPEUTICS INC | COM | 03152W109 |  | 17442 | 1428475 | SH |  | SOLE |  | 1428475 | 0 | 0 |
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 |  | 17317 | 334890 | SH |  | SOLE |  | 334890 | 0 | 0 |
| ARES ACQUISITION CORP | *W EXP 99/99/999 | G33032122 |  | 235 | 504706 | SH |  | SOLE |  | 504706 | 0 | 0 |
| ARVINAS INC | COM | 04335A105 |  | 14697 | 429600 | SH |  | SOLE |  | 429600 | 0 | 0 |
| ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 |  | 16370 | 134036 | SH |  | SOLE |  | 134036 | 0 | 0 |
| BERENSON ACQUISITION CORP I | *W EXP 08/01/202 | 083690115 |  | 31 | 862499 | SH |  | SOLE |  | 862499 | 0 | 0 |
| BILANDER ACQUISITION CORP | *W EXP 05/19/202 | 09001T114 |  | 33 | 183749 | SH |  | SOLE |  | 183749 | 0 | 0 |
| BRIDGETOWN HOLDINGS LTD | *W EXP 09/30/202 | G1355U121 |  | 103 | 895000 | SH |  | SOLE |  | 895000 | 0 | 0 |
| CATALYST PARTNERS ACQUISITION | *W EXP 05/12/202 | G19550121 |  | 1 | 336666 | SH |  | SOLE |  | 336666 | 0 | 0 |
| CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 |  | 16315 | 517287 | SH |  | SOLE |  | 517287 | 0 | 0 |
| CHURCHILL CAPITAL CORP V | *W EXP 10/29/202 | 17144T115 |  | 49 | 612000 | SH |  | SOLE |  | 612000 | 0 | 0 |
| CHURCHILL CAPITAL CORP VI | *W EXP 02/17/202 | 17143W119 |  | 32 | 540000 | SH |  | SOLE |  | 540000 | 0 | 0 |
| CHURCHILL CAPITAL CORP VII | *W EXP 02/29/202 | 17144M110 |  | 27 | 548000 | SH |  | SOLE |  | 548000 | 0 | 0 |
| COMPASS DIGITAL ACQUISITION CORP | *W EXP 09/29/202 | G2476C123 |  | 37 | 459906 | SH |  | SOLE |  | 459906 | 0 | 0 |
| CONCORD ACQUISITION CORP II | *W EXP 99/99/999 | 20607U116 |  | 47 | 408333 | SH |  | SOLE |  | 408333 | 0 | 0 |
| CONYERS PARK III ACQUISITION CORP | *W EXP 08/12/202 | 21289P110 |  | 85 | 571666 | SH |  | SOLE |  | 571666 | 0 | 0 |
| CORSAIR PARTNERING CORP | *W EXP 07/06/202 | G2540H116 |  | 110 | 334666 | SH |  | SOLE |  | 334666 | 0 | 0 |
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 |  | 15056 | 822745 | SH |  | SOLE |  | 822745 | 0 | 0 |
| CYTOKINETICS INC | COM NEW | 23282W605 |  | 18456 | 402793 | SH |  | SOLE |  | 402793 | 0 | 0 |
| DISH NETWORK CORPORATION | NOTE 12/1 | 25470MAF6 |  | 9645 | 15000000 | PRN |  | SOLE |  | 15000000 | 0 | 0 |
| FIRST LIGHT ACQUISITION GROUP INC | *W EXP 03/14/202 | 320703119 |  | 33 | 655200 | SH |  | SOLE |  | 655200 | 0 | 0 |
| GALAPAGOS NV | SPON ADR | 36315X101 |  | 17324 | 390359 | SH |  | SOLE |  | 390359 | 0 | 0 |
| HOME PLATE ACQUISITION CORP | *W EXP 09/30/202 | 43734R111 |  | 7 | 690000 | SH |  | SOLE |  | 690000 | 0 | 0 |
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 |  | 9876 | 1545589 | SH |  | SOLE |  | 1545589 | 0 | 0 |
| IVERIC BIO INC | COM | 46583P102 |  | 15150 | 707600 | SH |  | SOLE |  | 707600 | 0 | 0 |
| JAWS HURRICANE ACQUISITION CORP | *W EXP 03/26/202 | 47201B111 |  | 62 | 387249 | SH |  | SOLE |  | 387249 | 0 | 0 |
| LEVERE HOLDINGS CORP | *W EXP 03/09/202 | G5462L122 |  | 4 | 274999 | SH |  | SOLE |  | 274999 | 0 | 0 |
| MARBLEGATE ACQUISITION CORP | *W EXP 08/31/202 | 56608A113 |  | 29 | 735000 | SH |  | SOLE |  | 735000 | 0 | 0 |
| PROTHENA CORP PLC | SHS | G72800108 |  | 19455 | 322900 | SH |  | SOLE |  | 322900 | 0 | 0 |
| RELAY THERAPEUTICS INC | COM | 75943R102 |  | 10680 | 714848 | SH |  | SOLE |  | 714848 | 0 | 0 |
| ROSS ACQUISITION CORP II | *W EXP 02/01/202 | G7641C114 |  | 22 | 439666 | SH |  | SOLE |  | 439666 | 0 | 0 |
| SAGE THERAPEUTICS INC | COM | 78667J108 |  | 14561 | 381765 | SH |  | SOLE |  | 381765 | 0 | 0 |
| SAREPTA THERAPEUTICS INC | COM | 803607100 |  | 17034 | 131457 | SH |  | SOLE |  | 131457 | 0 | 0 |
| SENIOR CONNECT ACQUISITION COR | *W EXP 12/31/202 | 81723H116 |  | 61 | 1014000 | SH |  | SOLE |  | 1014000 | 0 | 0 |
| SKYDECK ACQUISITION CORP | *W EXP 05/13/202 | G82220115 |  | 7 | 361756 | SH |  | SOLE |  | 361756 | 0 | 0 |
| SOLID BIOSCIENCES INC | COM NEW | 83422E204 |  | 1176 | 218562 | SH |  | SOLE |  | 218562 | 0 | 0 |
| SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 |  | 16724 | 643000 | SH |  | SOLE |  | 643000 | 0 | 0 |
| SUMMIT HEALTHCARE ACQUISITION CORP | *W EXP 06/03/202 | G8566R110 |  | 139 | 489999 | SH |  | SOLE |  | 489999 | 0 | 0 |
| SWIFTMERGE ACQUISITION CORP | *W EXP 12/13/202 | G63836111 |  | 36 | 490000 | SH |  | SOLE |  | 490000 | 0 | 0 |
| TRAVERE THERAPEUTICS INC | COM | 89422G107 |  | 21583 | 1026300 | SH |  | SOLE |  | 1026300 | 0 | 0 |
| ZIMMER ENERGY TRANSITION ACQUISITION CORP | *W EXP 06/16/202 | 989570114 |  | 68 | 358270 | SH |  | SOLE |  | 358270 | 0 | 0 |

---